Research Article

Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker

Table 3

General information of the pathology subgroups of the lung cancer group.

ItemsScale cancerGland cancerSmall cell lung cancerUndiagnosed value

Number ()30242114
Sexuality (male/female)(29/1)(14/10)(16/5)(8/6)
Age (year)63 (59-71)58 (53-62.5)62 (53-68)62 (53-67)
(°C)36.7 (36.5-37.4)36.7 (36.45-38)36.8 (36.5-37.1)36.8 (36.6-37)
Pause (per/min)82 (76-86)84 (76-90)81 (74-84)81 (78-84)
Respiration (per/min)20 (19-20)20 (19.5-21.5)20 (18-20)20 (19-21)
SBP (mmHg)125 (110-132)126 (118-137)114 (110-130)111 (110-130)
DBP (mmHg)78 (70-80)78 (72-80)80 (70-80)70 (70-80)
WBC count (×109/L)6.31 (6.02-7.52)7.08 (6.41-8.34)6.16 (5.36-7.6)7.17 (5.18-10.77)
Neutrophil count (×109/L)4.64 (3.92-5.76)4.96 (4.06-6.40)4.61 (3.42-5.93)5.20 (3.7-8.88)
Neutrophil percentage (%)76.94 (66.5-81.84)74.2 (61.2-79.1)70.97 (65.05-74.2)70.2 (65.5-75.51)
Monocyte count (×109/L)0.41 (0.31-0.58)0.42 (0.29-0.56)0.45 (0.34-0.49)0.32 (0.26-0.52)
Monocyte percentage (%)6.00 (4.7-7.2)0.42 (0.29-0.55)0.45 (0.34-0.49)0.32 (0.26-0.52)